Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
A multi-component work participation program after post-acute cardiac rehabilitation (AmPULS): study protocol of a randomized controlled trial
ABSTRACT
Background:
Patients undergoing cardiac rehabilitation (CR) after an acute cardiac event are often at high risk of not returning to work. The number of patients with self-rated negative prognosis of employability is estimated at over 40%. Those patients have an increased risk that return to work fails within a year after completing CR.
Objective:
The AmPULS trial will test a multi-component intervention to improve work participation after post-acute CR.
Methods:
The randomized controlled trial recruits 297 patients attending in-patient post-acute CR aged between 18 and 62 years with a higher risk of not returning to work. Risk of not returning to work is determined by using a validated screening questionnaire (Würzburger Screening ≥1 point). Participants are randomly allocated to the intervention or the control group. The intervention group receives first telephone return to work counseling for 3 to 5 months and second, a one-week lasting rehabilitation service with specific work-related content in addition to usual care after CR discharge. The control group does not receive any additional intervention.
Results:
Outcomes: The primary outcome is self-rated work ability twelve months after discharge from post-acute CR. Secondary outcomes include employment status, physical and mental health, and other patient-reported health and functioning outcomes.
Conclusions:
The AmPULS trial will provide information on the fidelity of the implementation of a multi-component work participation intervention and its impact on return to work in working-age patients with a cardiovascular disease after CR. Clinical Trial: Prospectively registered into the German Clinical Trials Register (DRKS00033229) on January 10, 2024.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.